InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Foresite Capital Management IV, LLC. Director active across 1 company, notably Kinnate Biopharma Inc.. In total, 3 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €3.9m. History available since 8 May 2023. The latest transaction was filed on 8 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations